Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Cell Cycle ; 1(4): 262-6, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12429945

RESUMO

Patients with Bloom's syndrome (BS) show a strong genetic instability and a predisposition to all types of cancer. Here, we report that the Bloom's syndrome protein (BLM) is cleaved in response to hydroxyurea (HU)- or UVC-induced apoptosis. The appearance and solubility of BLM proteolytic products differed according to whether proteolysis occurred in response to HU or UVC. One BS cell line homozygous for a null mutation in BLM was resistant to both UVC- and HU-induced apoptosis, while another one expressing a mutated BLM protein was resistant to HU-induced apoptosis but displayed normal sensitivity to UVC. Thus, UVC and HU appear to induce apoptosis through distinct pathways.


Assuntos
Adenosina Trifosfatases/metabolismo , Antineoplásicos/farmacologia , Apoptose , Síndrome de Bloom/tratamento farmacológico , Síndrome de Bloom/radioterapia , DNA Helicases/metabolismo , Hidroxiureia/farmacologia , Raios Ultravioleta , Adenosina Trifosfatases/química , Terapia Combinada , DNA Helicases/química , Genes p53/genética , Humanos , Imuno-Histoquímica , Células K562 , RecQ Helicases , Fatores de Tempo , Células Tumorais Cultivadas
2.
Oncogene ; 21(13): 2079-88, 2002 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-11960380

RESUMO

Bloom's syndrome (BS) arises through mutations in both copies of the BLM gene that encodes a RecQ 3'-5' DNA helicase. BS patients are predisposed to developing all the cancers that affect the general population, and BS cells exhibit marked genetic instability. We showed recently that BLM protein contributes to the cellular response to ionizing radiation by acting as downstream ATM kinase effector. We now show that following UVC treatment, BLM-deficient cells exhibit a reduction in the number of replicative cells, a partial escape from the G2/M cell cycle checkpoint, and have an altered p21 response. Surprisingly, we found that hydroxyurea-treated BLM-deficient cells exhibit an intact S phase arrest, proper recovery from the S phase arrest, and intact p53 and p21 responses. We also show that the level of BLM falls sharply in response to UVC radiation. This UVC-induced reduction in BLM does not require a functional ATM gene and does not result from a subcellular compartment change. Finally, we demonstrate that exposure to UVC and hydroxyurea treatment both induce BLM phosphorylation via an ATM-independent pathway. These results are discussed in the light of their potential physiological significance with regard to the role of BLM in the cellular pathways activated by UVC radiation or HU-mediated inhibition of DNA synthesis.


Assuntos
Adenosina Trifosfatases/metabolismo , DNA Helicases/metabolismo , Replicação do DNA/efeitos dos fármacos , Replicação do DNA/efeitos da radiação , DNA/efeitos dos fármacos , Hidroxiureia/farmacologia , Raios Ultravioleta , Adenosina Trifosfatases/deficiência , Adenosina Trifosfatases/genética , Proteínas Mutadas de Ataxia Telangiectasia , Síndrome de Bloom/genética , Proteínas de Ciclo Celular , Divisão Celular/efeitos dos fármacos , Divisão Celular/efeitos da radiação , Inibidor de Quinase Dependente de Ciclina p21 , Ciclinas/metabolismo , DNA/biossíntese , DNA Helicases/deficiência , DNA Helicases/genética , Proteínas de Ligação a DNA , Citometria de Fluxo , Fase G2/efeitos dos fármacos , Fase G2/efeitos da radiação , Regulação da Expressão Gênica/efeitos da radiação , Humanos , Mitose/efeitos dos fármacos , Mitose/efeitos da radiação , Fosforilação/efeitos dos fármacos , Proteínas Serina-Treonina Quinases/metabolismo , RecQ Helicases , Fase S/efeitos dos fármacos , Fase S/efeitos da radiação , Fatores de Tempo , Células Tumorais Cultivadas , Proteína Supressora de Tumor p53/metabolismo , Proteínas Supressoras de Tumor
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA